Somatuline depot and Asa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Somatuline depot and Asa. Common interactions include arthralgia among females and nausea among males.

The phase IV clinical study analyzes what interactions people who take Somatuline depot and Asa have. It is created by eHealthMe based on reports of 10 people who take Somatuline depot and Asa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

10 people who take Somatuline depot and Asa together, and have interactions are studied.


What is Somatuline depot?

Somatuline depot has active ingredients of lanreotide acetate. It is often used in acromegaly. eHealthMe is studying from 2,625 Somatuline depot users for its effectiveness, alternative drugs and more.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 31,699 Asa users for its effectiveness, alternative drugs and more.

Number of Somatuline depot and Asa reports submitted per year:

Somatuline depot and Asa drug interactions.

Common Somatuline Depot and Asa drug interactions by gender *:

female:

  1. Arthralgia
  2. Joint swelling
  3. Abdominal pain upper
  4. Flatulence
  5. Alopecia
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Injection site bruising
  9. Injection site pain
  10. Urinary bladder haemorrhage

male:

  1. Nausea
  2. Injection site reaction
  3. Injection site mass
  4. Injection site pain
  5. Mitral valve disease
  6. Oedema
  7. Oedema peripheral
  8. Renal failure
  9. Tachycardia
  10. Abdominal pain

Common Somatuline Depot and Asa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia
  2. Joint swelling
  3. Haematocrit decreased
  4. Haemoglobin decreased
  5. Urinary bladder haemorrhage

50-59:

  1. Abdominal pain upper
  2. Blood glucose increased
  3. Chest pain
  4. Cough
  5. Ejection fraction decreased
  6. Face oedema
  7. Flatulence
  8. Hyperhidrosis
  9. Mitral valve disease
  10. Nausea

60+:

  1. Injection site reaction
  2. Nausea
  3. Pain in extremity
  4. Urinary tract infection
  5. Constipation
  6. Injection site bruising
  7. Injection site nodule
  8. Injection site pain
  9. Nodule
  10. Weight decreased

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 1 person, 10.00%
  2. Ovarian Cancer (cancer of ovary): 1 person, 10.00%
  3. Neuroendocrine Tumor: 1 person, 10.00%
  4. Metastatic Carcinoid Tumor: 1 person, 10.00%
  5. Insulin-Like Growth Factor Increased: 1 person, 10.00%
  6. High Blood Cholesterol: 1 person, 10.00%
  7. Diabetes: 1 person, 10.00%
  8. Colon Cancer: 1 person, 10.00%
  9. Carcinoid Tumor: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Somatuline depot and Asa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Somatuline depot and Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Somatuline depot interactions:

Browse all interactions between Somatuline depot and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Asa interactions:

Browse all interactions between Asa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lanreotide acetate and aspirin (the active ingredients of Somatuline depot and Asa, respectively), and Somatuline depot and Asa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: